Regulatory effect of iron regulatory protein-2 on iron metabolism in lung cancer

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 5514-5522

  Cheng, Z ^a   Dai, L L ^a   Song, Y N ^a   Kang, Y ^a   Si, J M ^a   Xia, J ^a   Liu, Y F ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Antisense oligonucleotide; Iron protein; Iron regulatory protein 2; Transferrin; Transferrin receptor

Indexed keywords

FERRITIN; IRON; IRON REGULATORY PROTEIN 2; MESSENGER RNA; TRANSFERRIN; TRANSFERRIN RECEPTOR; ANTISENSE OLIGONUCLEOTIDE;

ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DISEASE ACTIVITY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IRON METABOLISM; IRON REGULATORY PROTEIN 3 GENE; LUNG CANCER; LUNG CARCINOGENESIS; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; FERRITINS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IRON; IRON REGULATORY PROTEIN 2; LUNG NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, TRANSFERRIN; RNA, MESSENGER; TRANSFECTION; TRANSFERRIN;

EID: 84905014687     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.July.25.5     Document Type: Article

References (14)

1. Calzolari A, Oliviero I, Deaglio S, Mariani G, et al. (2007). Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood Cells Mol. Dis. 39: 82-91.
2. Calzolari A, Finisguerra V, Oliviero I, Deaglio S, et al. (2009). Regulation of transferrin receptor 2 in human cancer cell lines. Blood Cells Mol. Dis. 42: 5-13.
3. Choi SJ, Oh JM and Choy JH (2009). Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J. Inorg. Biochem. 103: 463-471.
4. Hausmann A, Lee J and Pantopoulos K (2011). Redox control of iron regulatory protein 2 stability. FEBS Lett. 585: 687-692.
5. Ikuta K, Yersin A, Ikai A, Aisen P, et al. (2010). Characterization of the interaction between diferric transferrin and transferrin receptor 2 by functional assays and atomic force microscopy. J. Mol. Biol. 397: 375-384.
6. Kaomongkolgit R, Cheepsunthorn P, Pavasant P and Sanchavanakit N (2008). Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells. Oral Oncol. 44: 587-594.
7. Kukulj S, Jaganjac M, Boranic M, Krizanac S, et al. (2010). Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer. Med. Oncol. 27: 268-277.
8. Le NT and Richardson DR (2004). Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. Blood 104: 2967-2975.
9. Maffettone C, Chen G, Drozdov I, Ouzounis C, et al. (2010). Tumorigenic properties of iron regulatory protein 2 (IRP2) mediated by its specific 73-amino acids insert. PLoS One 5: e10163.
10. Nurtjahja-Tjendraputra E, Fu D, Phang JM and Richardson DR (2007). Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression. Blood 109: 4045-4054.
11. Richardson DR, Kalinowski DS, Lau S, Jansson PJ, et al. (2009). Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim. Biophys. Acta 1790: 702-717.
12. Singh M, Mugler K, Hailoo DW, Burke S, et al. (2011). Differential expression of transferrin receptor (tfr) in a spectrum of normal to malignant breast tissues: Implications for in situ and invasive carcinoma. Appl. Immunohistochemistry Mol. Morphol. 19: 417-423.
13. Smilevska T, Stamatopoulos K, Samara M, Belessi C, et al. (2006). Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia. Leuk. Res. 30: 183-189.
14. Wang C, Ding C, Kong M, Dong A, et al. (2011). Tumor-targeting magnetic lipoplex delivery of short hairpin RNA suppresses IGF-1R overexpression of lung adenocarcinoma A549 cells in vitro and in vivo. Biochem. Biophys. Res. Commun. 410: 537-542.